Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetrathiomolybdate in Hormone Refractory Prostate Cancer
NCT00150995Phase 2Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- May 2001
- Primary completion
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tetrathiomolybdate in prostate cancer (PCa), sponsored by University of Michigan Rogel Cancer Center. Started May 2001; status: completed.
02
Drugs
tetrathiomolybdate
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00150995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150995.